Fundraising Fox

Jill Carroll

Investor

Operating Partner at SR One Capital Management · Board director at Airnexis Therapeutics Inc · Board director at Odyssey Therapeutics · Board director at Arcellx

East Coast (US)

About

Jill Carroll is an Operating Partner at SR One, which she first joined in 2011, and manages several of the firm's investments. She holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University. Before SR One, she worked in strategy consulting and biotech corporate development, including at Dynavax Technologies.

Contact· self-published, not guessed

Invests in

Biotech

Board director at Airnexis Therapeutics Inc

Intro paths

→

In turn, Jill can intro founders to Airnexis Therapeutics Inc's investors below.

Airnexis Therapeutics Inc's investors · 1

SR One Capital ManagementRedwood City · since 2026

Board director at Odyssey Therapeutics

Intro paths

→

In turn, Jill can intro founders to Odyssey Therapeutics's investors below.

Odyssey Therapeutics's investors · 13

Activant CapitalNew York · $100K – $50M checksAscenta CapitalWilmington · since 2023Balderton CapitalLondon · $5M – $50M checksCatalio Capital Management, LPNew YorkDimension CapitalSan Francisco · $1M – $10M checks · since 2025Foresite CapitalWest HollywoodGlobal BioAccess FundNew York · $10M checksGreatPoint VenturesSan Francisco · $250K – $20M checksJeito CapitalParis · since 2025Lightspeed Venture PartnersMenlo Park · $1.7M – $87M checksOrbiMedNew York · $1M – $75M checksSanofi VenturesCambridge · $5M checksSR One Capital ManagementRedwood City · since 2025

Co-founders at Odyssey Therapeutics

GD
Gary D GlickExecutive Officer, Director

Board director at Arcellx

Intro paths

→

In turn, Jill can intro founders to Arcellx's investors below.

Arcellx's investors · 9

LG Technology VenturesSanta ClaraNEA SecondaryTimonium · since 2023New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2022Norwest Venture PartnersMenlo Park · $10M – $30M checks · since 2019Quan CapitalShanghaiSamsara BioCapitalPalo AltoSixty Degree CapitalNorth YorkSolasta VenturesBostonSR One Capital ManagementRedwood City

Experience

  1. SR One Capital ManagementPartnercurrent2011 — present
  2. SR One Capital ManagementPrincipal2011
  3. Limerick BiopharmaVP, Corporate Development2010 — 2011
  4. Dynavax TechnologiesSr Director, Strategic Planning & Corporate Development2004 — 2010
  5. Clearview ProjectsDirector, Market Analysis2001 — 2004
  6. Mercer Management ConsultingConsultant1999 — 2001

Deals · 1

Odyssey TherapeuticsBoard seat

via SR One Capital Management · filed Dec 2025 · $214M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

92BioAirNexisArcellx (ACLX)Avalyn (AVLN)HotSpotOdysseyPoplar

Sources: SEC Form D filings · the firm's website.

Colleagues at SR One Capital Management

Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management

Network1

Deborah Harland
Partner at SR One Capital Management

Investors connected to Jill in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jill Carroll?
Jill Carroll is an Operating Partner at SR One, which she first joined in 2011, and manages several of the firm's investments. She holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University. Before SR One, she worked in strategy consulting and biotech corporate development, including at Dynavax Technologies.
Where does Jill Carroll work?
Jill Carroll is Operating Partner at SR One Capital Management and Board director at Airnexis Therapeutics Inc and Board director at Odyssey Therapeutics and Board director at Arcellx.
What does Jill Carroll invest in?
Jill Carroll invests in Biotech.
What boards does Jill Carroll sit on?
Jill Carroll holds tracked board seats at Odyssey Therapeutics.
What companies has Jill Carroll invested in?
Investments tracked here include 92Bio, AirNexis, Arcellx (ACLX), Avalyn (AVLN), HotSpot, Odyssey, Poplar.
Where did Jill Carroll go to school?
Jill Carroll studied at Johns Hopkins University (MS, Biochemistry); Duke University (Bachelor's degree, Chemistry).

Same school

Also attended Johns Hopkins University327

Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General Catalyst

+ 321 more

Also attended Duke University678

Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpScott RaneyManaging Director at Redpoint VenturesJack Bixby LucasGeneral Partner at Lucas Venture Group

+ 672 more

Shared employers

Also worked at SR One Capital Management31

Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundVikas GoyalPartner at Longwood FundEmily WarrenInvestor at Sandbox IndustriesSimeon J. GeorgeFounder & CEO at SR One Capital Management

+ 25 more

Also worked at Dynavax Technologies1

Jernej GodecPrincipal at Atlas Venture